By Ryan Davis ( June 24, 2019, 8:12 PM EDT) -- The Federal Circuit on Monday upheld a lower court's decision that a UCB patent covering Neupro, a patch used to treat Parkinson's disease, is infringed by a planned generic version from a company now owned by Teva, and also that a second patent on the product is invalid....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.